Growth Metrics

Resmed (RMD) Shares Repurchased (2018 - 2025)

Resmed's Shares Repurchased history spans 11 years, with the latest figure at $175.0 million for Q4 2025.

  • For Q4 2025, Shares Repurchased rose 133.4% year-over-year to $175.0 million; the TTM value through Dec 2025 reached $500.1 million, up 122.25%, while the annual FY2025 figure was $300.0 million, 100.0% up from the prior year.
  • Shares Repurchased reached $175.0 million in Q4 2025 per RMD's latest filing, up from $150.0 million in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $175.0 million in Q4 2025 to a low of $50.0 million in Q1 2024.
  • Average Shares Repurchased over 3 years is $86.1 million, with a median of $75.0 million recorded in 2024.
  • Peak YoY movement for Shares Repurchased: skyrocketed 49.95% in 2024, then surged 199.99% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $50.0 million in 2023, then surged by 49.95% to $75.0 million in 2024, then surged by 133.4% to $175.0 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Shares Repurchased are $175.0 million (Q4 2025), $150.0 million (Q3 2025), and $100.0 million (Q2 2025).